Literature DB >> 7540910

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.

D J Davidson1, J R Dorin, G McLachlan, V Ranaldi, D Lamb, C Doherty, J Govan, D J Porteous.   

Abstract

Lung disease is the major cause of death in cystic fibrosis (CF), but there is no evidence for overt lung involvement at birth. We show here that the same is true for the gene targeted cftrm1HGU mutant mouse. Furthermore, this CF mouse model demonstrates an impaired capacity to clear Staphylococcus aureus and Burkholderia (Pseudomonas) cepacia, two opportunistic lung pathogens closely associated with lung disease in CF subjects. The cftrm1HGU homozygotes display mucus retention and frank lung disease in response to repeated microbial exposure. Thus, lung disease in the cftrm1HGU mouse develops in response to bacterial infection, establishing a model to dissect the pathogenesis of CF pulmonary disease and providing a clinically relevant end point to assess the efficacy of pharmacologic or genetic interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7540910     DOI: 10.1038/ng0495-351

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  31 in total

1.  Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7.

Authors:  H Davidson; M S Taylor; A Doherty; A C Boyd; D J Porteous
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

2.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Vitamin D Receptor Deletion Leads to the Destruction of Tight and Adherens Junctions in Lungs.

Authors:  Honglei Chen; Rong Lu; Yong-Guo Zhang; Jun Sun
Journal:  Tissue Barriers       Date:  2018-11-08

Review 4.  Genetics and pulmonary medicine. 1. The genetics of cystic fibrosis lung disease.

Authors:  D J Davidson; D J Porteous
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

5.  Animal models of human disease for gene therapy.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

6.  Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection.

Authors:  E Berriatua; I Ziluaga; C Miguel-Virto; P Uribarren; R Juste; S Laevens; P Vandamme; J R Govan
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells.

Authors:  J D Li; W Feng; M Gallup; J H Kim; J Gum; Y Kim; C Basbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

8.  Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Authors:  Fadie T Coleman; Simone Mueschenborn; Gloria Meluleni; Christopher Ray; Vincent J Carey; Sara O Vargas; Carolyn L Cannon; Frederick M Ausubel; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

Review 9.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

10.  Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia.

Authors:  David R Koehler; Umadevi Sajjan; Yu-Hua Chow; Bernard Martin; Geraldine Kent; A Keith Tanswell; Colin McKerlie; Janet F Forstner; Jim Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.